Anthem closed the most recent trading day at $285.32, moving +0.08% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.16%. Meanwhile, the Dow lost 0.07%, and the Nasdaq, a tech-heavy index, lost 0.52%.
Coming into today, shares of the health insurer had gained 8.07% in the past month. In that same time, the Medical sector gained 4.4%, while the S&P 500 gained 3.12%.
ANTM will be looking to display strength as it nears its next earnings release. In that report, analysts expect ANTM to post earnings of $4.62 per share. This would mark year-over-year growth of 8.71%. Meanwhile, our latest consensus estimate is calling for revenue of $24.84 billion, up 9.36% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $19.29 per share and revenue of $100.16 billion, which would represent changes of +21.4% and +9.66%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for ANTM. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. ANTM is currently a Zacks Rank #3 (Hold).
Digging into valuation, ANTM currently has a Forward P/E ratio of 14.78. This valuation marks a premium compared to its industry's average Forward P/E of 14.64.
Investors should also note that ANTM has a PEG ratio of 1 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. ANTM's industry had an average PEG ratio of 1.04 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 16, which puts it in the top 7% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Image: Bigstock
Anthem (ANTM) Gains As Market Dips: What You Should Know
Anthem closed the most recent trading day at $285.32, moving +0.08% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.16%. Meanwhile, the Dow lost 0.07%, and the Nasdaq, a tech-heavy index, lost 0.52%.
Coming into today, shares of the health insurer had gained 8.07% in the past month. In that same time, the Medical sector gained 4.4%, while the S&P 500 gained 3.12%.
ANTM will be looking to display strength as it nears its next earnings release. In that report, analysts expect ANTM to post earnings of $4.62 per share. This would mark year-over-year growth of 8.71%. Meanwhile, our latest consensus estimate is calling for revenue of $24.84 billion, up 9.36% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $19.29 per share and revenue of $100.16 billion, which would represent changes of +21.4% and +9.66%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for ANTM. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. ANTM is currently a Zacks Rank #3 (Hold).
Digging into valuation, ANTM currently has a Forward P/E ratio of 14.78. This valuation marks a premium compared to its industry's average Forward P/E of 14.64.
Investors should also note that ANTM has a PEG ratio of 1 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. ANTM's industry had an average PEG ratio of 1.04 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 16, which puts it in the top 7% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.